Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49,779,938
-
Total 13F shares
-
25,928,974
-
Share change
-
+4,955,351
-
Total reported value
-
$424,968,625
-
Price per share
-
$16.39
-
Number of holders
-
79
-
Value change
-
+$85,947,257
-
Number of buys
-
40
-
Number of sells
-
31
Institutional Holders of Theravance Biopharma, Inc. - Common Stock (TBPH) as of Q4 2015
As of 31 Dec 2015,
Theravance Biopharma, Inc. - Common Stock (TBPH) was held by
79 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
25,928,974 shares.
The largest 10 holders included
BAUPOST GROUP LLC/MA, Woodford Investment Management Ltd, VANGUARD GROUP INC, FMR LLC, BlackRock Fund Advisors, OppenheimerFunds, Inc., FIRST MANHATTAN CO, BlackRock Institutional Trust Company, N.A., Rock Springs Capital Management LP, and STATE STREET CORP.
This page lists
79
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.